E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma

• Mina Maksimos,
• Barbara Muz,
• John L. Magnani,
• Abdel Kareem Azab

Affiliations

Mina Maksimos

Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine

Barbara Muz

Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine

John L. Magnani

GlycoMimetics Inc.

Abdel Kareem Azab

Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine